What is cagrilintide and how does it differ from semaglutide Cagrilintide: Long-acting amylin analog What cagrilintide is: Synthetic analog of amylin (human hormone) Long-acting formulation (weekly dosing) Developed by Novo Nordisk Currently in Phase 3 clinical trials Not yet FDA approved (as of 2024) Paired with semaglutide as "CagriSema" How amylin works naturally: Co-secreted with insulin from pancreatic beta cells Released after meals Slows gastric emptying (food stays in stomach longer) Reduces glucagon secretion Signals satiety to brain Regulates postprandial glucose Cagrilintide's mechanisms: Mimics natural amylin but lasts much longer Dramatically slows gastric emptying Increases satiety and fullness Reduces food intake Lowers postprandial glucose Works on amylin receptors (different from GLP-1) Primary benefits: Powerful appetite suppression Extended feeling of fullness Reduced meal frequency Lower caloric intake Glucose regulation Complements GLP-1 action Learn about peptides , how peptides work , and what are peptides used for in our foundational guides
Free radicals can damage the cell membrane, promote the body's aging, and induce tumor or hardening of the arteries of anti peroxidation to human cells, but also can improve the antioxidant ability of skin, make skin burnish
Glutation delivers a pure, foundational dose of glutathione alongside synergistic ingredients like turmeric and rosehip to promote antioxidant activity, immune strength, and detox support
Why We Picked Them: Ibrahim Elsheikh, MD, MBA leads the clinical team
Annu Rev Pharmacol Toxicol 45, 51-88 (2005)
Cognitive Function Research: Theres growing evidence that links lower VAT to better brain health
